[Tobramycin in pediatrics. Report of 24 cases].
Fournet
J P
JP
Huault
G
G
Castaing
H
H
Mariel
C
C
D000293:Adolescent; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring; D004363:Drug Utilization; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D018579:Patient Selection; D010372:Pediatrics / Q000379:methods* / Q000706:statistics & numerical data; D010818:Practice Patterns, Physicians' / Q000706:statistics & numerical data; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D014031:Tobramycin / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
D000900:Anti-Bacterial Agents; D014031:Tobramycin